-+ 0.00%
-+ 0.00%
-+ 0.00%

Profusa agrees to buy PanOmics Assay know-how assets from Bio Insights LLC

PUBT·05/05/2026 12:32:36
Listen to the news
Profusa agrees to buy PanOmics Assay know-how assets from Bio Insights LLC
  • Profusa entered an asset purchase agreement on April 21, 2026, to acquire substantially all know-how assets tied to Bio Insights’ PanOmics Assay platform.
  • PanOmics Assay is described as an integrated NGS multi-omics analysis platform spanning genomics, transcriptomics, metabolomics, aimed at drug discovery and precision medicine.
  • Deal remains subject to customary closing conditions, including stockholder approval for issuance of securities tied to transaction under Nasdaq rules.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profusa Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605050830PRIMZONEFULLFEED9713180) on May 05, 2026, and is solely responsible for the information contained therein.